CMIC Holdings Co Ltd represents a strong set of values and corporate philosophy. As a leading stock company, CMIC Holdings Co Ltd prioritizes integrity, innovation, and client satisfaction. With a commitment to excellence, CMIC Holdings Co Ltd aims to provide cutting-edge stock solutions and build strong partnerships with investors. The company values transparency, professionalism, and continuous growth. By leveraging their expertise and advanced technology, CMIC Holdings Co Ltd strives to deliver optimal financial services, thereby contributing to the success and prosperity of its clients.

CMIC Holdings Co Ltd is primarily present in Japan.

CMIC Holdings Co Ltd has achieved several significant milestones. One key milestone for the company was the establishment of its subsidiary CMIC Healthcare Co Ltd in 2013, which allowed CMIC Holdings to expand into the healthcare industry. Additionally, in 2016, CMIC Holdings Co Ltd successfully listed its shares on the Tokyo Stock Exchange, marking another important milestone in the company's history. Moreover, CMIC Holdings has been recognized globally for its innovative drug development services and has received numerous industry awards and accolades. These achievements reflect the company's strong growth and commitment to delivering high-quality services in the pharmaceutical and healthcare sectors.

CMIC Holdings Co Ltd, established in 1992, is a leading Japanese company specializing in providing comprehensive clinical development services in the pharmaceutical and medical field. With a rich history spanning nearly three decades, CMIC has successfully built a strong reputation through its commitment to quality, innovation, and customer satisfaction. The company offers a wide range of services, including clinical trials, regulatory affairs, medical affairs, and strategic consultancy. With a dedicated team of experts and cutting-edge technology, CMIC is well-positioned to support pharmaceutical companies throughout their product development journey. With its exceptional track record and industry expertise, CMIC Holdings Co Ltd has become a trusted partner in Japan's pharmaceutical sector.

The main competitors of CMIC Holdings Co Ltd in the market include Quintiles IMS Holdings Inc., ICON plc, and Pharmaceutical Product Development (PPD) Inc. These companies are prominent players in the contract research organization (CRO) industry, which is CMIC Holdings' primary market segment. CMIC Holdings Co Ltd faces tough competition from these industry-leading firms in providing comprehensive clinical trial and research services, regulatory consulting, and quality assurance solutions. Maintaining a strong market position requires CMIC Holdings' continuous focus on innovation, exceptional client service, and delivering highly efficient and cost-effective solutions to pharmaceutical, biotechnology, and medical device companies.

CMIC Holdings Co Ltd is primarily active in the industries of contract research organization (CRO) services, clinical development, and pharmaceutical development.

CMIC Holdings Co Ltd is a Japanese company with a unique business model in the healthcare industry. The company offers a comprehensive range of contract research and development (R&D) services to pharmaceutical, biotechnology, and medical device companies. CMIC Holdings Co Ltd focuses on providing integrated solutions for the entire drug development process, including clinical trials, regulatory support, data management, and post-marketing studies. With its expertise and extensive network, the company plays a crucial role in accelerating the development and commercialization of new medicines and healthcare products. CMIC Holdings Co Ltd's business model emphasizes collaboration, efficiency, and innovation to meet the dynamic needs of the global healthcare market.

Az CMIC Holdings Co P/E mutatója 12,27.

Az CMIC Holdings Co KUV 0,58.

Az AlleAktien Minőségi Score CMIC Holdings Co esetében 7/10.

A várt CMIC Holdings Co forgalma 78,78 milliárd JPY.

A(z) várt CMIC Holdings Co nyereség 3,70 milliárd JPY.

CMIC Holdings Co Ltd is a Japanese company that offers a wide range of services in the healthcare industry. The company is based in Tokyo and has been active for over 30 years. CMIC provides support in areas such as drug development, clinical trials, regulatory and health-related market research, and pharmaceutical distribution logistics. The company's product range is diverse and includes both consulting and operational services. One of the main business sectors is drug development, where the company offers a full-service platform that covers all necessary steps from preclinical development to approval and market launch of a drug. This includes safety and efficacy testing of drugs, competition analysis, dossier submission to regulatory authorities, and clinical trial logistics. Another important offering from CMIC is the conduct of clinical trials. The company takes care of planning, conducting, and analyzing studies in Japan and the US. To support study coordination, CMIC also provides a digital platform that facilitates data exchange with study centers. Regulatory Affairs is another business sector of CMIC, where the company offers support for submission of approval applications. This includes checking approval dossiers, collaborating with regulatory authorities, and monitoring risks and product recalls. CMIC also provides health-related market research, conducting investigations into specific diseases as well as markets for medical devices, diagnostics, and drugs. CMIC is also active in this field as a provider of big data analysis to optimize the healthcare industry as a whole. Pharmaceutical logistics is another important sector of CMIC. The company operates its own warehousing and offers handling services for the import and export of drugs and medical devices. CMIC also handles the direct shipment of drugs to clinics and pharmacies. In addition to the mentioned business sectors, CMIC also offers customer services for its entire product range. Customers can choose customized solutions tailored to the needs of their companies. CMIC also provides tailored support for the development of marketing strategies. Overall, CMIC is a comprehensive service provider in the healthcare industry. The company has expanded internationally in recent years and offers its services in other countries such as the US. With its wide portfolio, the company is well-positioned to meet the growing demands of the healthcare market.

A(z) CMIC Holdings Co évente alkalommal oszt ki 15,00 JPY összegű osztalékot.

A CMIC Holdings Co esetében jelenleg nem lehet kiszámítani a osztalékot, vagy a vállalat nem fizet osztalékot.

A(z) CMIC Holdings Co ISIN kódja: JP3359000001.

A CMIC Holdings Co WKN-je 663202.

Az CMIC Holdings Co tőzsdei rövidítése 2309.T.

Az elmúlt 12 hónapban a(z) CMIC Holdings Co osztalékot fizetett 50,00 JPY összegben. Ez körülbelül 1,89 % osztalékhozamnak felel meg. A következő 12 hóban a(z) CMIC Holdings Co várhatóan 61,39 JPY összegű osztalékot fog fizetni.

A(z) CMIC Holdings Co jelenlegi osztalékhozama 1,89 %.

A(z) CMIC Holdings Co negyedévente fizet osztalékot. Az osztalékokat a következő hónapokban osztják ki: április, október, április, október.

A CMIC Holdings Co az elmúlt 23 évben minden évben fizetett osztalékot.

A következő 12 hónapban 61,39 JPY összegű osztalékra számítanak. Ez 2,32 % osztalékhozamnak felel meg.

A(z) CMIC Holdings Co a(z) 'Egészség' szektorhoz van besorolva.

Az utolsó, CMIC Holdings Co által 2023. 12. 01.-án/én fizetett 45 JPY összegű osztalék megszerzéséhez a részvénynek az ex-nap előtti 2023. 09. 28.-nál kellett lennie a portfóliódban.

Az utolsó osztalék kifizetése 2023. 12. 01. időpontban történt.

2023 évben a CMIC Holdings Co 15 JPY összegű osztalékot fizetett ki.

Az CMIC Holdings Co osztalékait JPY fizeti ki.